PURPLE BIOTECH LTD. (PPBT) Operating margin 2019–2022
PURPLE BIOTECH LTD. (PPBT) operating margin by fiscal year — reported operating income divided by reported revenue.
-2260.3%FY2022 · since FY2019: -7156.0% → -2260.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -2260.3% | -466.9 pp |
| FY2021 | -1793.4% | -532.2 pp |
| FY2020 | -1261.2% | +5894.8 pp |
| FY2019 | -7156.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More PPBT financial trends
PPBT RevenuePPBT Net incomePPBT Net marginPPBT Gross profitPPBT Gross marginPPBT Operating incomePPBT Operating cash flowPPBT Free cash flowPPBT Capital expendituresPPBT Return on equityPPBT Stock buybacksPPBT Dividends paidPPBT Total assetsPPBT Total liabilitiesPPBT Shareholders’ equityPPBT overview →